Aligning Science Across Parkinson's Logo Text

Ex vivo culture of SPMs protocol used in “LRRK2-G2019S Synergizes with Ageing and Low-Grade Inflammation to Promote Gut and Peripheral Immune Cell Activation that Precede Nigrostriatal Degeneration”

By Carmela Giachino, PhD, Federico Bertoli, MD, Michela Deleidi, MD, PhD, Bianca Marchetti
View Published Protocol

Output Details

Description
Ex vivo culture of SPMs protocol used in "LRRK2-G2019S Synergizes with Ageing and Low-Grade Inflammation to Promote Gut and Peripheral Immune Cell Activation that Precede Nigrostriatal Degeneration"
Identifier (DOI)
10.17504/protocols.io.8epv5jpdjl1b/v1
Team
Team Schapira
Program
Collaborative Research Network
Theme
Neuro-Immune Interactions

Meet the Authors

Related Research

Protocols Suite — SH-SY5Y / iCell® Neurons / High-Content Imaging

Maintenance of SH-SY5Y cells with SNCA overexpression in DMEM/F-12, differentiation with RA/BDNF, and culture of iCell DopaNeurons with SNCA mutation. Treatment and immunostaining for downstream assays using specific protocols and analysis tools.

View Protocol

Immunofluorescencent Staining of A-synuclein, TFEB, GCase and LAMP1 in treated cultured cells

Protocol used to detect a-synuclein, TFEB, GCase, and LAMP1 via immunofluorescence in SH-SY5Y cells with mutant SNCA gene.

View Protocol

GCase activity assay

Protocol measures GCase activity using 4-MUG substrate. GCase protein from a cellular model is diluted in acidic buffer to mimic lysosome pH. Adding lipid/detergent maintains enzyme activity. Taurocholate bile salt is included in the protocol.

View Protocol
View More Outputs
Aligning Science Across Parkinson's
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.